Crohn’s disease drugmakers to benefit from expected rise in cases
NSA Digital Archive/iStock via Getty Images Pharmaceutical companies that market drugs for Crohn's disease -- or have ones in development -- are poised to benefit from an expected rise in cases of the inflammatory bowel disease. As of…
